Biotech

As companies continue to adapt to the changing funding environment, we collaborate closely with our clients to predict their development challenges and to help them advance their pipelines.

Our understanding of the growing regulatory pressures that companies experience allows us to help clients thoughtfully navigate towards the next milestone while managing costs and program execution effectively.

We mitigate the known risks brought with impending partner/acquirer evaluations through our participation in due diligence activities and our objective evaluation of the acquisition candidate's value proposition.  

On the sell side, we support the client at early stages of development by facilitating and leading a thoughtful planning process, thereby bringing a deep understanding of what future due diligence and integration will entail.